Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:54 pm Purchase | 2023-12-31 | 13G | Forte Biosciences, Inc. FBRX | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 145,219 9.990% | 145,219 (New Position) | Filing History |
| 2023-02-14 10:52 am Sale | 2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,231,427 3.900% | -396,982 (-15.10%) | Filing History |
| 2022-05-11 4:03 pm Sale | 2022-05-09 | 13D | Exicure, Inc. XCUR | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 39,042 4.770% | -2,625 (-6.30%) | Filing History |
| 2022-03-14 09:29 am Sale | 2022-03-08 | 13D | Bicycle Therapeutics plc BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,408,259 4.800% | -549,702 (-28.08%) | Filing History |
| 2022-02-14 12:06 pm Sale | 2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 5.800% | -36,000 (-1.35%) | Filing History |
| 2022-01-03 09:26 am Sale | 2021-12-30 | 13G | TPG Pace Beneficial Finance Corp. TPGY | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 0 0.000% | -4,957,302 (Position Closed) | Filing History |
| 2021-04-09 11:50 am Purchase | 2021-03-31 | 13G | TPG Pace Beneficial Finance Corp. TPGY | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 4,957,302 14.200% | 4,957,302 (New Position) | Filing History |
| 2021-02-16 12:09 pm Sale | 2020-12-31 | 13G | FARFETCH LTD FTCHQ | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 5,354,942 1.800% | -12,716,435 (-70.37%) | Filing History |
| 2020-11-12 09:11 am Unchanged | 2020-11-05 | 13D | Bicycle Therapeutics plc BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 9.200% | 0 (Unchanged) | Filing History |
| 2020-07-20 09:51 am Unchanged | 2020-06-30 | 13D | Bicycle Therapeutics plc BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 10.800% | 0 (Unchanged) | Filing History |
| 2020-05-29 09:21 am Purchase | 2020-05-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 7.400% | 2,664,409 (New Position) | Filing History |
| 2020-02-14 12:07 pm Purchase | 2019-12-31 | 13G | FARFETCH LTD FTCHQ | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 18,071,377 7.000% | 18,071,377 (New Position) | Filing History |